|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 800 Maine AVE SW |
Address2 | Suite 900 |
| City | Washington |
State | DC |
Zip Code | 20024-2002 |
Country | USA |
3. Principal place of business (if different than line 2)
| City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 3151-12
|
||||||||
|
6. House ID# 304890000
|
||||||||
| TYPE OF REPORT | 8. Year | 2025 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Mike Troubh |
Date | 4/18/2025 1:58:57 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
H.R. 9747 - Continuing Appropriations and Extensions Act, 2025
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Executive Office of the President (EOP)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mikael |
Troubh |
|
|
|
Daniel |
Stanford |
III |
|
|
Dana |
Doran |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
H.R. 21/S. 6 - Born-Alive Abortion Survivors Protection Act
H.R.1096 - HOPE and Mental Wellbeing Act of 2025
H.R. 929/S. 266 - Lorna Breen Health Care Provider Protection Reauthorization
H.R. 593 - Strengthening Pathways to Health Professions Act
H.R. 879 - Medicare Patient Access and Practice Stabilization Act
H.R. 1153 - Rural America Health Corps Act
S. 475 - Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act
H.R. 1735/S. 779 - EARLY Minds Act
H.R. 1448 - PEER for Mental Health Act
H.R. 1585/S. 709 - Conrad State 30 and Physician Access Reauthorization Act
H.R. 1909 - Preventing Maternal Deaths Reauthorization Act of 2025
H.R. 2028/ S. 942 - Resident Education Deferred Interest Act (REDI Act)
H.R. 957 - Parity Enforcement Act
H.R. 2509/S. 931 - COMPLETE Care Act
S. 1264 - CONNECT for Health Act
H.R. 1305 - Improving Measurements for Loneliness and Isolation Act
H.R. 1902 - Helping Emergency Responders Overcome (HERO) Act
H.R. 2223 - Building Capacity for Care Act
H.R. 2586 - Reentry Act of 2025
Mental Health Matters Act
GME draft legislation
Medicare Mental Health Inpatient Equity Act
Telemental Health Care Access Act
Mental Health Infrastructure Improvement Act of 2025
Letter to Congress in support of the Prevention and Public Health Fund
Letter to Congress to extend telehealth flexibilities
Letter to Congress for funding for public health research into firearm morbidity and mortality prevention at CDC, NIH and NIJ.
Letter to Congress on Agency for Healthcare Research and Quality (AHRQ) funding
Letter to Congress on funding for FDAs Neurology Drug Program in FY26
Letter to Congress on funding for the BRAIN Initiative in FY26
Letter to Congress regarding school-based Medicaid programs
Letters to Congress in support of Medicaid
Letter to NIH regarding indirect cost caps for NIH grants
Letter to HHS/OCR in response to the HIPAA Security Rule to Strengthen the cybersecurity of electronic protected health information
Letter to HHS regarding the use of psychiatric medications for the treatment of pediatric mental illness and substance use disorder.
Response to AHRQ RFI regarding the Impact of Ageism in Healthcare.
Conversation with GAO regarding CMS distribution of medical residency slots as authorized by Section 126 of the Consolidated Appropriations Act, 2021
Communication with EBSA regarding their meeting with APA members and Councils at APAs annual meeting.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Executive Office of the President (EOP), Office of Management & Budget (OMB), Health & Human Services - Dept of (HHS), Labor - Dept of (DOL), Treasury - Dept of, Food & Drug Administration (FDA), Natl Institutes of Health (NIH), Government Accountability Office (GAO), Agency for Healthcare Research & Quality (AHRQ)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mikael |
Troubh |
|
|
|
Daniel |
Stanford |
III |
|
|
Dana |
Doran |
|
|
|
Becky |
Yowell |
|
|
|
Maureen |
Maguire |
|
|
|
Brooke |
Trainum |
|
|
|
Abigail |
Griffin |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
H.R. 241 - Sergeant Ted Grubbs Mental Healthcare for Disabled Veterans Act
H.R. 1107 - Protecting Veteran Access to Telemedicine Services Act
H.R. 1987/ S. 926 - Saving Our Veterans Lives Act
H.R. 2426/ S. 702 - Veterans Mental Health and Addiction Therapy Quality of Care Act
Letter to Secretary Collins in support of physician exemptions to return to office
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Veterans Affairs - Dept of (VA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Daniel |
Stanford |
III |
|
|
Abigail |
Griffin |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
Response to DEA proposed rule on Special Registration for Telemedicine and Limited State Telemedicine Registrations.
Communication with FDA regarding the removal of the Clozapine REMS program.
17. House(s) of Congress and Federal agencies Check if None
Drug Enforcement Administration (DEA), Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Brooke |
Trainum |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Letter to the Administration regarding Contract Year 2026 Policy and Technical Changes to the Medicare Advantage Program.
Letter to the Administration regarding policy recommendations related to Medicare Physician Fee schedule.
17. House(s) of Congress and Federal agencies Check if None
Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Maureen |
Maguire |
|
|
|
Becky |
Yowell |
|
|
|
Brooke |
Trainum |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
| Lobbyist Name | Description of Offense(s) |